|
| No. | Age/gender/laterality | Etiology | Clinical presentation | Systemic diseases | Leukocyte count (initial vs. final) | Blood culture | CT or MRI | Treatment | Length of stay (days) | Time of postoperation (days) | Initial VA | Final VA | Prognosis |
|
| 1 | 44/M/OD | Traumatic | Blepharedema, ophthalmoplegia, exophthalmia | N/A | 10.85–6.64 | Negative | CT | Intravitreal injection (twice) | 9 | 4 | NLP | NLP | Recovered |
| 2 | 41/M/OD | Endogenous | Blepharedema, exophthalmia | Diabetes | 13.8–8.6 | Negative | CT | Intravitreal injection (twice) | 28 | 12 | LP | NLP | Recovered |
| 3 | 87/M/OD | After cataract surgery | Blepharedema, ophthalmoplegia, exophthalmia | Pulmonary embolism | 12.7–5.93 | Negative | CT | Evisceration of eye contents | 7 | 7 | NLP | NLP | Recovered |
| 4 | 28/F/OS | Endogenous | Blepharedema, exophthalmia | Diabetes hypertension uremia | 12.1–9.98 | Negative | CT | Evisceration of eye contents | 12 | 6 | NLP | NLP | Recovered |
| 5 | 64/F/OS | Traumatic | Blepharedema, exophthalmia | Hypertension | 10.09–4.70 | Negative | CT MRI | Evisceration of eye contents | 12 | 7 | NLP | NLP | Recovered |
| 6 | 28/M/OD | Traumatic | Blepharedema, exophthalmia | N/A | 14.85–5.6 | Negative | CT | Intravitreal injection (once) | 10 | 10 | NLP | NLP | Recovered |
| 7 | 65/M/OS | Corneal perforation | Blepharedema | N/A | 10.18–6.2 | Negative | CT | Enucleation | 12 | 4 | NLP | NLP | Recovered |
| 8 | 29/M/OD | Traumatic | Blepharedema | N/A | 23.08–13.7 | Negative | CT MRI | Intravitreal injection (once) | 16 | 12 | 20/200 | NLP | Recovered |
| 9 | 60/M/OD | Endogenous | Blepharedema, exophthalmia | Diabetes hypertension cervical abscess | 12.5–8.7 | Klebsiella pneumoniae | CT MRI | Abscess incision, vitrectomy, intravitreal injection | 19 | 4 | NLP | NLP | Recovered |
| 10 | 87/M/OS | Endogenous | Blepharedema, ophthalmoplegia, exophthalmia | Pulmonary encephalopathy | 15.4–8.25 | Negative | CT | Evisceration of eye contents | 6 | 4 | NLP | NLP | Recovered |
| 11 | 63/F/OS | Endogenous | Blepharedema, exophthalmia | N/A | 9.1–7.4 | Negative | CT | Vitrectomy intravitreal injection | 9 | 7 | NLP | NLP | Recovered |
| 12 | 65/M/OD | Endogenous | Blepharedema, ophthalmoplegia, exophthalmia | COPD hypertension | 17.4–8.46 | Negative | CT MRI | Abscess incision | 5 | 5 | NLP | NLP | Recovered |
| 13 | 71/F/OS | Endogenous | Blepharedema, ophthalmoplegia, exophthalmia | Liver abscess | 21.84–7.8 | Negative | CT | Enucleation | 17 | 10 | NLP | NLP | Recovered |
| 14 | 34/M/OD | Traumatic | Blepharedema | N/A | 12.46–8.21 | Negative | CT | Evisceration of eye contents | 10 | 5 | NLP | NLP | Recovered |
| 15 | 77/M/OS | Endogenous | Blepharedema | Liver abscess hypertension cerebral infarction | 12.92–9.0 | Negative | CT | Conservative | 9 | N/A | NLP | NLP | Recovered |
| 16 | 45/M/OS | Endogenous | Blepharedema | Sepsis hypertension | 13.05–8.91 | Klebsiella pneumoniae | CT | Conservative | 15 | N/A | NLP | NLP | Recovered |
| 17 | 73/F/OD | Corneal perforation | Blepharedema | N/A | 12.6–6.94 | Negative | CT MRI | Conservative | 7 | N/A | NLP | NLP | Recovered |
|
